QCG
TBIO

Quadrant Capital Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Quadrant Capital Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-38
Closed -$1K – 2732
2021
Q2 		$1K Sell
38
-81
-68% -$1.59K ﹤0.01% 2380
2021
Q1 		$2K Buy
119
+81
+213% +$1.84K ﹤0.01% 2149
2020
Q4 		$1K Hold
38
– – ﹤0.01% 2260
2020
Q3 		$1K Buy
+38
New +$586 ﹤0.01% 2131

Quadrant Capital Group's TBIO Position: Q3 2021 in Review

Quadrant Capital Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 38 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Quadrant Capital Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Quadrant Capital Group sold 38 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Quadrant Capital Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Quadrant Capital Group's Translate Bio, Inc. Common Stock position peaked at $2K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.